Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein

Biomedicine and Pharmacotherapy

Volumn 70, Issue C, 2015, Pages 140-145

  Nabekura, Tomohiro ^a,b   Hiroi, Takashi ^b   Kawasaki, Tatsuya ^a   Uwai, Yuichi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Anticancer drug; Drug transporter; NF B; P glycoprotein; Phytochemical

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALOE EMODIN; ALPHA AMYRIN; ANACARDIC ACID; ANETHOLE; ANTINEOPLASTIC AGENT; BUTEIN; CELASTROL; DAUNORUBICIN; EMODIN; ESTER DERIVATIVE; EUGENOL; HONOKIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LICOCHALCONE A; LUPEOL; MAGNOLOL; MASLINIC ACID; MULTIDRUG RESISTANCE PROTEIN; NATURAL PRODUCT; PROTEIN INHIBITOR; RHODAMINE 123; THYMOQUINONE; TUMOR NECROSIS FACTOR ALPHA; VINBLASTINE; WITHAFERIN A; XANTHOHUMOL; ZERUMBONE; BIOLOGICAL PRODUCT; BIPHENYL DERIVATIVE; FLAVONOID; LIGNAN; PROPIOPHENONE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; ANTAGONISTS AND INHIBITORS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; FLAVONOIDS; HUMANS; LIGNANS; NF-KAPPA B; P-GLYCOPROTEIN; PROPIOPHENONES;

EID: 84927512179     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.01.007     Document Type: Article

References (41)

1. Ambudkar S., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999, 39:361-398.
2. Szakács G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2005, 5:219-234.
3. Ueda K. ABC proteins protect the human body and maintain optimal health. Biosci Biotechnol Biochem 2011, 75:401-409.
4. Ueda K., Cornwell M.M., Gottesman M.M., Pastan I., Roninson I.B., Ling V., et al. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986, 141:956-962.
5. Kitagawa S., Nabekura T., Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 2004, 56:1001-1005.
6. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., et al. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005, 28:2274-2278.
7. Nabekura T., Kamiyama S., Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 2005, 327:866-870.
8. Nabekura T., Yamaki T., Ueno K., Kitagawa S. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals. Cancer Chemother Pharmacol 2008, 62:867-873.
9. Nabekura T., Yamaki T., Ueno K., Kitagawa S. Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1. Biochem Biophys Res Commun 2008, 369:363-368.
10. Nabekura T., Yamaki T., Kitagawa S. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Eur J Pharmacol 2008, 600:45-49.
11. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006, 441:431-436.
12. Inoue J., Gohda J., Akiyama T., Semba K. NF-κB activation in development and progression of cancer. Cancer Sci 2007, 98:268-274.
13. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012, 26:203-234.
14. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3:768-780.
15. Aggarwal B.B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006, 71:1397-1421.
16. Aggarwal B.B., Kunnumakkara A.B., Harikumar K.B., Tharakan S.T., Sung B., Anand P. Potential of spice-derived phytochemicals for cancer prevention. Planta Med 2008, 74:1560-1569.
17. Ueda K., Shimabuku A.M., Konishi H., Fujii Y., Takabe S., Nishi K., et al. Functional expression of human P-glycoprotein in Schizosaccaromycespombe. FEBS Lett 1993, 330:279-282.
18. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992, 267:4854-4858.
19. Natarajan K., Singh S., Burke T.R., Grunberger D., Aggarwal B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci USA 1996, 93:9090-9095.
20. Funakoshi-Tago M., Tanabe S., Tago K., Itoh H., Mashino T., Sonoda Y., et al. Licochalcone A potently inhibits tumor necrosis factor a-induced nuclear factor-κB activation through the direct inhibition of IκB kinase complex activation. Mol Pharmacol 2009, 76:745-753.
21. Sung B., Pandey M.K., Ahn K.S., Yi T., Chaturvedi M.M., Liu M., et al. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBa kinase, leading to potentiation of apoptosis. Blood 2008, 111:4880-4891.
22. Lee J.H., Koo T.H., Yoon H., Jung H.S., Jin H.Z., Lee K., et al. Inhibition of NF-κB activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 2006, 72:1311-1321.
23. Harikumar K.B., Kunnumakkara A.B., Ahn K.S., Anand P., Krishnan S., Guha S., et al. Modification of the cysteine residues in IκBα kinase and NF-κB (p65) by xanthohumol leads to suppression of NF-κB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood 2009, 113:2003-2013.
24. Ahn K.S., Sethi G., Shishodia S., Sung B., Arbiser J.L., Aggarwal B.B. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway. Mol Cancer Res 2006, 4:621-633.
25. Saleem M., Afaq F., Adhami V.M., Mukhtar H. Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004, 23:5203-5214.
26. Medeiros R., Otuki M.F., Avellar M.C., Calixto J.B. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene α-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Eur J Pharmacol 2007, 559:227-235.
27. Huang L., Guan T., Qian Y., Huang M., Tang X., Li Y., et al. Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B. Eur J Pharmacol 2011, 672:169-174.
28. Kaileh M., Vanden Berghe W., Heyerick A., Horion J., Piette J., Libert C., et al. Withaferin A strongly elicits IκB kinase β hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 2007, 282:4253-4264.
29. Jiang J., Grieb B., Thyagarajan A., Sliva D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med 2008, 21:577-584.
30. Pandey M.K., Sandur S.K., Sung B., Sethi G., Kunnumakkara A.B., Aggarwal B.B. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)- κB and NF-κB-regulated gene expression through direct inhibition of IκBα kinase β on cysteine 179 residue. J Biol Chem 2007, 282:17340-17350.
31. Takada Y., Murakami A., Aggarwal B.B. Zerumbone abolishes NF-κB and IκBα kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005, 24:6957-6969.
32. Sethi G., Ahn K.S., Aggarwal B.B. Targeting nuclear factor-κB activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 2008, 6:1059-1070.
33. Kumar A., Dhawan S., Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-κB activation, IκB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 1998, 17:913-918.
34. Lin M.L., Lu Y.C., Chung J.G., Wang S.G., Lin H.T., Kang S.E., et al. Down-regulation of MMP-2 through the p38 MAPK-NF-κB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion. Mol Carcinog 2010, 49:783-797.
35. Chainy G.B., Manna S.K., Chaturvedi M.M., Aggarwal B.B. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000, 19:2943-2950.
36. Scotto K.W. Transcriptional regulation of ABC drug transporters. Oncogene 2003, 22:7496-7511.
37. Um J.H., Kang C.D., Lee B.G., Kim D.W., Chung B.S., Kim S.H. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene 2001, 20:6048-6056.
38. Kuo M.T., Liu Z., Wei Y., Lin-Lee Y.C., Tatebe S., Mills G.B., et al. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling. Oncogene 2002, 21:1945-1954.
39. Belliard A.M., Lacour B., Farinotti R., Leroy C. Effect of tumor necrosis factor-a and interferon-y on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J Pharm Sci 2004, 93:1523-1536.
40. Lee G., Piquette-Miller M. Cytokines alter the expression and activity of the multidrug resistance transporters in human hepatoma cell lines; analysis using RT-PCR and cDNA microarrays. J Pharm Sci 2003, 92:2152-2163.
41. Geick A., Eichelbaum M., Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 2001, 276:14581-14587.